|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.150 CNY | 0.00% |
|
+2.79% | +0.59% |
| 07-29 | Jointown Pharmaceutical Plans Up to 2.2-Billion-Yuan Factoring | MT |
| 07-16 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| Market Cap | 25.68B 3.8B 3.3B 3.08B 2.83B 5.34B 362B 5.43B 36.37B 14.24B 181B 14.28B 13.96B 596B | P/E 2026 * |
11x | P/E 2027 * | 10.2x |
|---|---|---|---|---|---|
| Enterprise Value | 21.36B 3.16B 2.75B 2.57B 2.35B 4.44B 301B 4.52B 30.25B 11.85B 150B 11.88B 11.61B 496B | EV / Sales 2026 * |
0.13x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.06% | Yield 2027 * | 4.33% |
| 1 week | +2.79% | ||
| 1 month | +6.19% | ||
| 3 months | -0.39% | ||
| Current year | +0.59% |
| 1 week | 4.97 | 5.2 | |
| 1 month | 4.86 | 5.28 | |
| Current year | 4.48 | 5.84 | |
| 1 year | 4.48 | 5.84 | |
| 3 years | 4.35 | 6.94 | |
| 5 years | 3.97 | 6.94 | |
| 10 years | 3.97 | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Hua Gong
CEO | Chief Executive Officer | 48 | 14/10/2024 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 14/11/2023 |
Wei He
CEO | Chief Executive Officer | 40 | 22/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gu Liang Tang
BRD | Director/Board Member | 64 | 04/11/2020 |
Bao Lin Liu
CHM | Chairman | 73 | 31/10/2008 |
Zhao Nian Liu
BRD | Director/Board Member | 66 | 15/11/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/06/24 | Buy | Chief Executive Officer | 60,494 | 0.0015% | ||
| 07/06/24 | Buy | 3,025 | 0.0001% | |||
| 07/06/24 | Buy | Director | 1,210 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +2.79% | -6.02% | -2.09% | 3.8B | ||
| -0.67% | +0.20% | +19.81% | +95.76% | 100B | ||
| +1.24% | +1.31% | +46.48% | +147.78% | 53.87B | ||
| +1.02% | +4.58% | +3.85% | +278.34% | 23.74B | ||
| -0.30% | +2.63% | -12.90% | -14.50% | 8.37B | ||
| -1.86% | -0.03% | -34.67% | -31.07% | 7.56B | ||
| +0.46% | +3.68% | -7.32% | -27.10% | 6.92B | ||
| -2.80% | -3.45% | +19.42% | +17.61% | 6.16B | ||
| -1.63% | -2.98% | -2.98% | +21.48% | 5.29B | ||
| -2.29% | -2.07% | +11.32% | +15.78% | 3.7B | ||
| Average | -0.62% | +1.09% | +3.70% | +50.20% | 21.97B | |
| Weighted average by Cap. | -0.05% | +1.56% | +19.50% | +108.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 25.13B 21.84B 20.39B 18.72B 35.3B 2,396B 35.91B 240B 94.17B 1,195B 94.4B 92.31B 3,940B | 180B 26.62B 23.13B 21.6B 19.83B 37.38B 2,537B 38.03B 255B 99.73B 1,265B 99.97B 97.76B 4,173B |
| Net income | 2.36B 349M 303M 283M 260M 490M 33.24B 498M 3.34B 1.31B 16.57B 1.31B 1.28B 54.67B | 2.56B 379M 329M 307M 282M 532M 36.09B 541M 3.62B 1.42B 18B 1.42B 1.39B 59.37B |
| Net Debt | -4.32B -640M -556M -519M -476M -898M -60.96B -914M -6.12B -2.4B -30.4B -2.4B -2.35B -100B | -5.04B -746M -649M -606M -556M -1.05B -71.15B -1.07B -7.14B -2.8B -35.48B -2.8B -2.74B -117B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/08/26 | CN¥5.150 | 0.00% | 28,083,420 |
| 31/07/26 | CN¥5.150 | 0.00% | 39,474,521 |
| 30/07/26 | CN¥5.150 | +0.59% | 37,447,008 |
| 29/07/26 | CN¥5.120 | +1.99% | 36,208,510 |
| 28/07/26 | CN¥5.020 | -1.18% | 32,464,890 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
















